This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This is a firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Aging to Oxford Nanopore Technologies Inc., a division of the parent company Oxford Nanopore Technologies PLC. The $355,400 contract is for the provision of full-length RNA sequencing supplies to support the work of the National Institute on Aging. The contract has a completion date of June 15, 2022 and was originally awarded on September 16,...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $20,000 purchase order to Oxford Nanopore Technologies Inc. for SOFTWARE LICENSE AND DEVICE WARRANTY SERVICES - PROMETHION-24 SEQUENCER. Oxford Nanopore Technologies Inc. will provide software licenses and device warranty services for its PromethION-24 sequencer under the firm fixed price contract. Performance will take place in Baltimore, Maryland over a one year period from August...
This is a $23,050.00 firm fixed price purchase order awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of a PromethION 2 Solo CAPEX Sequencing Unit, a next-generation genomic sequencing platform developed by Oxford Nanopore. This award is not associated with a set-aside program and is the latest in a...
This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...
This federal contract award, valued at $22,600, was issued by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the procurement of SCIENTIFIC EQUIPMENT - PROMETHION FLOW CELLS, with a completion date of Nov 15, 2024. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for analyzing single molecules, including DNA, RNA,...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $3 million firm fixed price purchase order to Oxford Nanopore Technologies Inc., a division of Oxford Nanopore Technologies PLC, to provide long read sequencing kits to the Laboratory of Neurogenetics for neurodegenerative disease research. The two month contract will support the laboratory's efforts to advance understanding of conditions such as Alzheimer's and Parkinson's diseases....
This is a $232,150 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian federal agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PROMETHION FLOW CELL PACKS, which are a key consumable component of Oxford Nanopore's PromethION sequencing platform. The contract has a period of performance through May 1, 2028. Oxford Nanopore Technologies Inc. is an established federal...
This federal contract award, valued at $304,104.91, was made by the National Institute on Aging (NIA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PromethION flow cells and accessories to support long-read sequencing on Oxford Nanopore's sequencing systems. This equipment will be used by the NIA's Center for Alzheimer's Disease and Related Dementias to identify causative genes for neurodegenerative diseases as part...
Oxford Nanopore Technologies Inc. was awarded a $555,600 firm-fixed-price purchase order by the National Institutes of Health's National Institute on Aging to provide Oxford Nanopore Long Read Sequencing Kits. The contract calls for one PromethION 48 Starter Pack and one PromethION Flow Cell 72 pack, to be delivered within six months to the place of performance in Cambridge, Massachusetts. The solicitation sought quotes for these long read sequencing products and services to support research...
The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $197,755 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of a PROMETHION 24 THIRD GENERATION SEQUENCER to support the NIA's Computational Biology & Genomics Core, which provides next-generation sequencing services for aging-related research at the NIA Intramural Research Program (NIA IRP). The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a prime contractor that has also served as a subcontractor on federal contracts, providing sequencing platforms, consumables, and services to various government agencies, including the Centers for Disease Control and Prevention, U.S. Department of Agriculture, and Department of Defense, to support diverse research initiatives.